Press Releases
LEO Pharma Leverages Veeva Link for Key People to Expand Engagement with Scientific Experts
Veeva Systems announced that it has expanded its partnership with LEO Pharma, a global leader in medical dermatology, to drive relevant discussions with the...
News
Carcinogen Concern Leads To Pfizer Drug Recall From The US
Pfizer's recall saga has now reached the United States, after elevated concentrations of potential carcinogens forced the company to pull multiple products in Canada....
News
Catalent Buys A NJ Cell Therapy Facility For $44.5 Million
Catalent, the high-flying CDMO, is buying a cell therapy unit on the East Coast, only days after spending $350 million to strengthen up biologics...
News
First Malaria Vaccine Protects Around A Million African Kids
More than a million children in Ghana, Kenya, and Malawi have been given one or more doses of the world’s first malaria vaccine, owing...
News
NorthX Biologics signs GMP manufacturing collaboration agreement with Abera Bioscience
Sweden-based NorthX Biologics, which focuses on process development and large-scale production of advanced biological drugs, has signed a collaboration agreement with Abera Bioscience for...
News
Tower Cold Chain wins Queen’s Award for International Trade
Pharmaceutical temperature-controlled specialist Tower Cold Chain has been honoured with a Queen’s Award for Enterprise, the UK’s highest accolade for business success. The company...
News
Ontario and Quebec become the first provinces to list Kesimpta for the treatment of adults with relapsing remitting multiple sclerosis
Novartis Pharmaceuticals Canada Inc. is pleased to announce that PrKesimpta® (ofatumumab) is now covered under the Ontario Exceptional Access Program (EAP) and included on the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read